NEW YORK (GenomeWeb News) – Population Genetics Technologies said today that it has secured a £2,000,000 ($3.2 million) investment from previous investors in the privately held genomics analysis technologies firm.

The company said it earned this second tranche of the Series A funding by meeting certain commercial and developmental milestones set by its principal investors.

The Cambridge, UK-based firm's initial seed funding came from the Wellcome Trust, and its Series A investors include Auriga Partners, Beringea, and Compass Genetics Investors.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.